SURGY vs TAVHL Comparison
Price, market cap, valuation, profitability and leverage metrics of SURGY and TAVHL side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | SURGY | TAVHL | Sector median |
|---|---|---|---|
| Last price (TL) | 20.70 | 268.00 | 6.81 |
| Daily change | −4.96% | −1.74% | −3.54% |
| Market cap | TRY 3.5B | TRY 97.4B | TRY 5.5B |
| P/E | — | 18.79 | 7.35 |
| P/B | 0.34 | 1.21 | 0.45 |
| Dividend yield | — | 0.65% | 1.34% |
| Return on equity | −8.06% | 6.51% | 0.92% |
| Free float | 29.70% | 49.67% | 28.00% |
Popular comparisons
Related pages
About the SURGY vs TAVHL comparison
Price, market cap, valuation multiples, profitability and leverage of SURGY (Sur Tatil Evleri GMYO) and TAVHL (Tav Havalimanlari) side by side as of Sep 28, 2026, 11:57. Of the 11 metrics compared, SURGY leads in 5 and TAVHL leads in 6.
Highlights: Daily change: TAVHL leads (−1.74% vs −4.96%). Market cap: TAVHL leads (TRY 97.4B vs TRY 3.5B). P/B: SURGY leads (0.34 vs 1.21). EV/Sales: TAVHL leads (4.20 vs 204.54). Gross margin: SURGY leads (47.03% vs 33.56%). EBITDA margin (annual): SURGY leads (2,129.73% vs 30.49%). Net margin (annual): TAVHL leads (5.65% vs −1,274.66%). Return on assets: TAVHL leads (2.05% vs −5.70%).
Frequently asked questions
Is SURGY or TAVHL cheaper?
By P/E, Tie is cheaper (— vs 18.79); by P/B, SURGY trades at the lower multiple (0.34 vs 1.21).
Which is more profitable, SURGY or TAVHL?
Annual net margin is −1,274.66% for SURGY and 5.65% for TAVHL; return on equity is −8.06% for SURGY and 6.51% for TAVHL.
Which is more leveraged, SURGY or TAVHL?
The leverage ratio is 30.27 for SURGY and 68.91 for TAVHL; net debt/EBITDA is — for SURGY and 3.18 for TAVHL. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.